KR930701475A - 사람의 거핵구-집락 촉진 인자(hMeg-CSF) 및 그것의 생산방법 - Google Patents

사람의 거핵구-집락 촉진 인자(hMeg-CSF) 및 그것의 생산방법

Info

Publication number
KR930701475A
KR930701475A KR1019920703438A KR920703438A KR930701475A KR 930701475 A KR930701475 A KR 930701475A KR 1019920703438 A KR1019920703438 A KR 1019920703438A KR 920703438 A KR920703438 A KR 920703438A KR 930701475 A KR930701475 A KR 930701475A
Authority
KR
South Korea
Prior art keywords
csf
hmeg
protein
page
daltons
Prior art date
Application number
KR1019920703438A
Other languages
English (en)
Korean (ko)
Inventor
제이. 머피 마틴
이. 파크먼트 랄프
엘. 에릭슨-밀러 코니
웨이 다이
자오젱 장
에이. 리오타 렌스
크루츠스키 헨리
Original Assignee
원본미기재
히플 캔서 리서치 센타
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 원본미기재, 히플 캔서 리서치 센타 filed Critical 원본미기재
Publication of KR930701475A publication Critical patent/KR930701475A/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Analytical Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
KR1019920703438A 1990-07-02 1991-07-02 사람의 거핵구-집락 촉진 인자(hMeg-CSF) 및 그것의 생산방법 KR930701475A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US54757390A 1990-07-02 1990-07-02
US547,573 1990-07-02
PCT/US1991/004698 WO1992000319A1 (en) 1990-07-02 1991-07-02 Human meg-csf protein and methods

Publications (1)

Publication Number Publication Date
KR930701475A true KR930701475A (ko) 1993-06-11

Family

ID=24185193

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019920703438A KR930701475A (ko) 1990-07-02 1991-07-02 사람의 거핵구-집락 촉진 인자(hMeg-CSF) 및 그것의 생산방법

Country Status (7)

Country Link
EP (1) EP0540575A4 (fi)
JP (1) JPH06502621A (fi)
KR (1) KR930701475A (fi)
AU (1) AU8215591A (fi)
CA (1) CA2086248A1 (fi)
FI (1) FI925983A0 (fi)
WO (1) WO1992000319A1 (fi)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260417A (en) * 1989-04-03 1993-11-09 Genetics Institute, Inc. Megakaryocyte growth promoting activity protein
US6433142B1 (en) 1989-08-08 2002-08-13 Genetics Institute, Llc Megakaryocyte stimulating factors
CN1103782C (zh) * 1994-03-31 2003-03-26 安姆根有限公司 单聚乙二醇化的mgdf多肽
US5795569A (en) * 1994-03-31 1998-08-18 Amgen Inc. Mono-pegylated proteins that stimulate megakaryocyte growth and differentiation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4894440A (en) * 1986-09-17 1990-01-16 Massachusetts Institute Of Technology Method of isolating megakaryocyte stimulatory factor
WO1990003397A1 (en) * 1988-09-21 1990-04-05 Meiji Seika Kaisha, Ltd. Novel megakaryocytic colony stimulating factor and process for its preparation
DK0487613T3 (da) * 1989-08-08 1996-11-25 Genetics Inst Megakarycytopiesk faktor

Also Published As

Publication number Publication date
WO1992000319A1 (en) 1992-01-09
AU8215591A (en) 1992-01-23
CA2086248A1 (en) 1992-01-03
JPH06502621A (ja) 1994-03-24
EP0540575A4 (en) 1994-06-08
FI925983A (fi) 1992-12-31
FI925983A0 (fi) 1992-12-31
EP0540575A1 (en) 1993-05-12

Similar Documents

Publication Publication Date Title
EP0209539B1 (en) Homogeneous erythropoietin
CA2067744A1 (en) The human c3b/c4b receptor (cr1)
KR900701824A (ko) 동물 감염의 치료 또는 예방을 위한 조성물 및 그 방법
DE69226592T2 (de) Neue neutrophilaktivierende Faktoren
JPH05500211A (ja) 造巨核球因子
ZA892397B (en) The human c3b/c4b receptor(cr1)
JPH01502397A (ja) Ｍ―ｃｓｆの生産方法
EA003777B1 (ru) Конъюгаты эритропоэтина, их применение, фармацевтические композиции и способы лечения
JPH05503512A (ja) 白血球接着阻害因子としての［ａｌａ　ｉｌ―８］↓７↓７
KR930701475A (ko) 사람의 거핵구-집락 촉진 인자(hMeg-CSF) 및 그것의 생산방법
US7311903B2 (en) Glycosylated human interferon alpha isoform
EP0306870A2 (de) Gamma-Interferon-Derivate, Herstellungsverfahren, Vektoren dafür und Arzneimittel daraus
DE69232259T2 (de) Verfahren zur Herstellung von Interleukin-6 Zusammensetzungen
US7229809B2 (en) Use of modified lysozyme c to prepare medicinal compositions for the treatment of some serious diseases
US5440022A (en) Hepatokine and methods for its use
EP0308424A1 (en) A novel protein, neuroleukin
EP0256042A1 (en) Interleukin
CA2156850A1 (fr) Facteurs de croissance de la famille de l'harp, procede d'obtention et aplications
DE19729810C2 (de) Mittel zur Sepsistherapie, seine Herstellung und seine Verwendung
Kamis et al. {BLR 1792} Amgen-EPO-Genetics Institute-Ortho: Round Two: Genetics Institute Sues Ortho over Reissued Erythropoietin Patent

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid